Denutrition, cachexia and osteoporosis;Dénutrition, cachexie et ostéoporose

Revue du Rhumatisme Monographies

Volumn 80, Issue 2, 2013, Pages 100-104

  El Maghraoui, Abdellah ^a  

^a MILITARY HOSPITAL MOHAMMED V   (Morocco)

Author keywords

Cachexia; Cachexie; D nutrition; Denutrition; Elderly; Fractures; Fragilit ; Frailty; Ost oporose; Osteoporosis; Sarcop nie; Sarcopenia; Sujet g

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CACHEXIA; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FALL RISK; FRAIL ELDERLY; HUMAN; KIDNEY FAILURE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; MUSCLE ATROPHY; MUSCLE MASS; MUSCLE STRENGTH; NUTRITIONAL REQUIREMENT; NUTRITIONAL STATUS; OSTEOPOROSIS; PATHOLOGIC FRACTURE; PROGNOSIS; PROTEIN CALORIE MALNUTRITION; PUBLIC HEALTH PROBLEM; RHEUMATOID ARTHRITIS; RISK FACTOR; SHORT SURVEY; WEIGHT REDUCTION;

EID: 84877121847     PISSN: 18786227     EISSN: 22120920     Source Type: Journal    
DOI: 10.1016/j.monrhu.2012.11.005     Document Type: Short Survey

References (56)

1. HAS. Stratégie de prise en charge en cas de dénutrition protéinoénergétique chez la personne âgée. In: Recommandations; www.has-sante.fr. 2007.
2. Walston J.D. Sarcopenia in older adults. Curr Opin Rheumatol 2012, 24:623-627.
3. Cooper C., Dere W., Evans W., et al. Frailty and sarcopenia: definitions and outcome parameters. Osteoporos Int 2012, 23:1839-1848.
4. Lainscak M., Podbregar M., Anker S.D. How does cachexia influence survival in cancer, heart failure and other chronic diseases?. Curr Opin Support Palliat Care 2007, 1:299-305.
5. Aversa Z., Bonetto A., Costelli P., et al. beta-hydroxy-beta-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia. Int J Oncol 2011, 38:713-720.
6. Jeejeebhoy K.N. Malnutrition, fatigue, frailty, vulnerability, sarcopenia and cachexia: overlap of clinical features. Curr Opin Clin Nutr Metab Care 2012, 15:213-219.
7. Tan B.H., Fearon K.C. Cachexia: prevalence and impact in medicine. Curr Opin Clin Nutr Metab Care 2008, 11:400-407.
8. Riaudel T., Guillot P., De Decker L., et al. Nutrition and osteoporosis in elderly. Geriatr Psychol Neuropsychiatr Vieil 2011, 9:399-408.
9. Prentice A. Diet, nutrition and the prevention of osteoporosis. Public Health Nutr 2004, 7:227-243.
10. Geinoz G., Rapin C.H., Rizzoli R., et al. Relationship between bone mineral density and dietary intakes in the elderly. Osteoporos Int 1993, 3:242-248.
11. Tucker K.L. Osteoporosis prevention and nutrition. Curr Osteoporos Rep 2009, 7:111-117.
12. Beasley J.M., Ichikawa L.E., Ange B.A., et al. Is protein intake associated with bone mineral density in young women?. Am J Clin Nutr 2010, 91:1311-1316.
13. D'Erasmo E., Pisani D., Ragno A., et al. Relationship between serum albumin and bone mineral density in postmenopausal women and in patients with hypoalbuminemia. Horm Metab Res 1999, 31:385-388.
14. Lee H.P., Chang Y.Y., Jean Y.H., et al. Importance of serum albumin level in the preoperative tests conducted in elderly patients with hip fracture. Injury 2009, 40:756-759.
15. Laulund A.S., Lauritzen J.B., Duus B.R., et al. Routine blood tests as predictors of mortality in hip fracture patients. Injury 2012, 43:1014-1020.
16. Tucker K.L., Chen H., Hannan M.T., et al. Bone mineral density and dietary patterns in older adults: the Framingham Osteoporosis Study. Am J Clin Nutr 2002, 76:245-252.
17. Baylink D., Lau K.H., Mohan S. The role of IGF system in the rise and fall in bone density with age. J Musculoskelet Neuronal Interact 2007, 7:304-305.
18. Yakar S., Rosen C.J., Beamer W.G., et al. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 2002, 110:771-781.
19. Langlois J.A., Rosen C.J., Visser M., et al. Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab 1998, 83:4257-4262.
20. Ammann P., Bourrin S., Bonjour J.P., et al. Protein undernutrition-induced bone loss is associated with decreased IGF-I levels and estrogen deficiency. J Bone Miner Res 2000, 15:683-690.
21. Schurch M.A., Rizzoli R., Slosman D., et al. Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998, 128:801-809.
22. Lencel P., Magne D. Inflammaging: the driving force in osteoporosis?. Med Hypotheses 2011, 76:317-321.
23. Rizzoli R. Nutrition: its role in bone health. Best Pract Res Clin Endocrinol Metab 2008, 22:813-829.
24. Rosenberg I.H. Sarcopenia: origins and clinical relevance. J Nutr 1997, 127:990S-1000S.
25. Rolland Y., Abellan van Kan G., Gillette-Guyonnet S., et al. Cachexia versus sarcopenia. Curr Opin Clin Nutr Metab Care 2011, 14:15-21.
26. Schaap L.A., Pluijm S.M., Deeg D.J., et al. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 2006, 119:e9-e17.
27. Sayer A.A. Sarcopenia. BMJ 2010, 341:c4097.
28. Visser M., Schaap L.A. Consequences of sarcopenia. Clin Geriatr Med 2011, 27:387-399.
29. Janssen I. The epidemiology of sarcopenia. Clin Geriatr Med 2011, 27:355-363.
30. Abellan van Kan G. Epidemiology and consequences of sarcopenia. J Nutr Health Aging 2009, 13:708-712.
31. Rivier E., Krieg M.A., Lamy O. Sarcopenia: definition, methods of measurement, therapeutic future. Rev Med Suisse 2011, 7:1047-1048.
32. Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in older people. Age Ageing 2010, 39:412-423.
33. Verschueren S., Gielen E., O'Neill T.W., et al. Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men. Osteoporos Int 2012, [doi:10.1007/s00198-012-2057-z].
34. Szulc P., Beck T.J., Marchand F., et al. Low skeletal muscle mass is associated with poor structural parameters of bone and impaired balance in elderly men--the MINOS study. J Bone Miner Res 2005, 20:721-729.
35. Tinetti M.E., Speechley M., Ginter S.F. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988, 319:1701-1707.
36. Cummings-Vaughn L.A., Gammack J.K. Falls, osteoporosis, and hip fractures. Med Clin North Am 2011, 95:495-506. [x].
37. Ensrud K.E., Ewing S.K., Taylor B.C., et al. Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci 2007, 62:744-751.
38. Di Monaco M., Castiglioni C., Vallero F., et al. Sarcopenia is more prevalent in men than in women after hip fracture: a cross-sectional study of 591 inpatients. Arch Gerontol Geriatr 2012, 55:e48-e52.
39. Bonjour J.P., Schurch M.A., Rizzoli R. Nutritional aspects of hip fractures. Bone 1996, 18:139S-144S.
40. Schiper L., Sadigursky D., Rosario D.A., et al. Hip fracture prognosis: could bioimpedance be an alternative to conventional nutritional assessment?. Nutr Hosp 2012, 26:904-906.
41. Jallut D., Tappy L., Kohut M., et al. Energy balance in elderly patients after surgery for a femoral neck fracture. JPEN J Parenter Enteral Nutr 1990, 14:563-568.
42. Ip T.P., Leung J., Kung A.W. Management of osteoporosis in patients hospitalized for hip fractures. Osteoporos Int 2010, 21:S605-S614.
43. Summers G.D., Deighton C.M., Rennie M.J., et al. Rheumatoid cachexia: a clinical perspective. Rheumatology (Oxford) 2008, 47:1124-1131.
44. Roubenoff R., Roubenoff R.A., Cannon J.G., et al. Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 1994, 93:2379-2386.
45. Morley J.E., Thomas D.R., Wilson M.M. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 2006, 83:735-743.
46. Engvall I.L., Elkan A.C., Tengstrand B., et al. Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability, and low bioavailable insulin-like growth factor. Scand J Rheumatol 2008, 37:321-328.
47. Fukuda W., Omoto A., Oku S., et al. Contribution of rheumatoid arthritis disease activity and disability to rheumatoid cachexia. Mod Rheumatol 2010, 20:439-443.
48. Elkan A.C., Engvall I.L., Cederholm T., et al. Rheumatoid cachexia, central obesity and malnutrition in patients with low-active rheumatoid arthritis: feasibility of anthropometry, mini nutritional assessment and body composition techniques. Eur J Nutr 2009, 48:315-322.
49. van Bokhorst-de van der Schueren M.A., Konijn N.P., Bultink I.E., et al. Relevance of the new pre-cachexia and cachexia definitions for patients with rheumatoid arthritis. Clin Nutr 2012, 31:1008-1010.
50. Bohler C., Radner H., Ernst M., et al. Rheumatoid arthritis and falls: the influence of disease activity. Rheumatology (Oxford) 2012, 51:2051-2057.
51. Roux C. Osteoporosis in inflammatory joint diseases. Osteoporos Int 2011, 22:421-433.
52. El Maghraoui A., Rezqi A., Mounach A., et al. Prevalence and risk factors of vertebral fractures in women with rheumatoid arthritis using vertebral fracture assessment. Rheumatology (Oxford) 2010, 49:1303-1310.
53. Metsios G.S., Stavropoulos-Kalinoglou A., Douglas K.M., et al. Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia. Rheumatology (Oxford) 2007, 46:1824-1827.
54. Marcora S.M., Chester K.R., Mittal G., et al. Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis. Am J Clin Nutr 2006, 84:1463-1472.
55. Evans W.J., Morley J.E., Argiles J., et al. Cachexia: a new definition. Clin Nutr 2008, 27:793-799.
56. Springer J., von Haehling S., Anker S.D. The need for a standardized definition for cachexia in chronic illness. Nat Clin Pract Endocrinol Metab 2006, 2:416-417.